Investor
The General Catalyst Institute, launched in the U.S. in September, is expanding into India and inviting policymakers and entrepreneurs in the region to collaborate.
Sanofi invests in Zucara Therapeutics and MintNeuro raises $1.27 million in a funding round.
According to Bloomberg, the brain-implant chipmaker raised $93 million in funding, increasing the startup's valuation to approximately $500 million.
HATCo will spend a total of $550 million in capital funding to invest in technologies and innovation.
The guidance aims to help countries move toward healthcare digitization through a person-centered point of service system.
The company also reported Q3 2024 earnings, noting total revenue of $76.4 million, adjusted EBITDA of $7.3 million and a net loss of $14.7 million.
The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.
Last week, the wearables company announced it opened an investigation into apparent manipulation in trading its common shares following a 1-for-15 reverse stock split.
The investigation follows shareholder approval of a 1-for-15 reverse stock that took effect earlier this week.